CorMedix, Inc. (CRMD)
7.26
+0.03
(+0.41%)
USD |
NASDAQ |
Apr 16, 09:36
CorMedix Research and Development Expense (Quarterly) : 8.60M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Pfizer Inc. | 3.133B |
| Amicus Therapeutics, Inc. | 23.74M |
| Altimmune, Inc. | 18.38M |
| Insmed, Inc. | 254.91M |
| Theravance Biopharma, Inc. | 6.963M |